Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Founded in 2020, the New Mexico Society of Clinical Oncology (NMSCO) is a powerful community of multidisciplinary care providers involved in treating patients with cancer. NMSCO is a state Chapter Member of the Association of Cancer Care Centers (ACCC) and a State Affiliate of the American Society of Clinical Oncology (ASCO). Members receive valuable educational content and innovative …
Founded in 2015, the Montana State Oncology Society (MSOS) is a powerful community of multidisciplinary care providers involved in treating patients with cancer. MSOS is a state Chapter Member of the Association of Cancer Care Centers (ACCC) and a State Affiliate of the American Society of Clinical Oncology (ASCO). Members receive valuable educational content and innovative resources …
Founded in 2022, the Arkansas Association of Cancer Professionals (AACP) is a powerful community of multidisciplinary care providers involved in treating patients with cancer. AACP is a state Chapter Member of the Association of Cancer Care Centers (ACCC) and a State Affiliate of the American Society of Clinical Oncology (ASCO). Members receive valuable educational content and innovative …
• Learning and networking with peers and Industry representatives at Educational Series; • Advocacy support to address policies that affect oncology care, including legislative updates on state and federal issues; legislative participation through an interactive advocacy platform; collaboration with peers on state-level advocacy initiatives; and access to policy committee; • Leadership …
Founded in 1992, the Iowa Oncology Society (IOS) is a powerful community of multidisci- plinary care providers involved in treating patients with cancer. IOS is a state Chapter Member of the Association of Cancer Care Centers (ACCC) and a State Affiliate of the American Society of Clinical Oncology (ASCO). Members receive valuable educational content and innovative resources designed …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. SCOS ONCOLOGY DRUG NEWSLETTER A P R I L 2 0 2 4 FDA APPROVALS Nivolumab (Opdivo) Nivolumab (Opdivo) plus cisplatin-based chemotherapy has been approved by the FDA for the treatment of patients with treatment-naive unresectable …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. NCOA ONCOLOGY DRUG NEWSLETTER A P R I L 2 0 2 4 FDA APPROVALS Nivolumab (Opdivo) Nivolumab (Opdivo) plus cisplatin-based chemotherapy has been approved by the FDA for the treatment of patients with treatment-naive unresectable …
TxSCO Update April 2024 Copyright© 2024 ADVI Health. All Rights Reserved.Copyright© 2024 ADVI Health. All Rights Reserved.1 TxSCO Update April 11, 2024 ADVI & HillCo Copyright© 2024 ADVI Health. All Rights Reserved.2 Federal • Provider Reimbursement • Medicare Payment Cuts • MACRA Reforms: Senate Working Group • NYT: MultiPlan’s Impact on Provider Reimbursements …
Reviewers: Lu Anne, Sarah Sender: TACOS Target: TACOS Members Subject Line: Your April Oncology Newsletter Is Here! Pre-Header: Review April Drug Updates & Upcoming Meetings in Your State Link banner to: https://www.accc-cancer.org/state-societies/Arizona/tacos-homepage Your Oncology Newsletter: April 2024 edition has arrived! This monthly digital publication—a benefit of TACOS …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TACOS ONCOLOGY DRUG NEWSLETTER A P R I L 2 0 2 4 FDA APPROVALS Nivolumab (Opdivo) Nivolumab (Opdivo) plus cisplatin-based chemotherapy has been approved by the FDA for the treatment of patients with treatment-naive unresectable …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TxSCO ONCOLOGY DRUG NEWSLETTER A P R I L 2 0 2 4 FDA APPROVALS Nivolumab (Opdivo) Nivolumab (Opdivo) plus cisplatin-based chemotherapy has been approved by the FDA for the treatment of patients with treatment-naive unresectable …
April 13, 2024
Immerse yourself in exhilarating discussions and innovative ideas for overcoming the most relevant and daunting challenges in oncology to-date. Hear from local and national visionaries on effective practices for delivering optimal care, make new connections—and strengthen existing ones—through unlimited networking opportunities, and stay ahead of the curve on the latest industry trends. Secure your …
April 13, 2024
Join us in Scottsdale, AZ and experience a collaborative forum that unites leading experts from across the state to explore clinical advances in oncology care, nuances of new existing treatments, and the impact of national policies on state level initiatives. Secure your complimentary spot today! PROVIDER REGISTRATIONVIEW AGENDA Provider Registration - inclusive of licensed physicians and allied health …
April 13, 2024
You’re invited to participate in the Targeted Oncology™ Community Case Forum™ on Saturday, April 13 at Sheraton Overland Park Hotel at the Convention Center in Overland Park, Kansas. Healthcare Research & Analytics offers compensation of $750 to medical oncologists/hematologists for their consultative insights. With prior approval from our registration team, a small number of fellows and advanced …
April 12, 2024
You’re invited to participate in the Targeted Oncology™ Community Case Forum™ on Friday, April 12 at Inn at Andaz Scottsdale Resort & Bungalows in Scottsdale, Arizona. This event will take place the evening before the TACOS 2024 Spring Conference. Healthcare Research & Analytics offers compensation of $750 to medical oncologists/hematologists for their consultative insights. With prior approval …
ACCC 41ST NATIONAL ONCOLOGY CONFERENCE REALIZING INNOVATION Sponsorship & Exhibit Prospectus For more information, contact: ACCC Corporate Relations & Development Sabina Gargiulo, sgargiulo@accc-cancer.org www.accc-cancer.org/NOC October 9-11, 2024 | Hilton Minneapolis | Minneapolis, MN 2 ACCC 41st National Oncology Conference …
SKIN CANCER Awareness Month SKIN CANCER IS THE MOST COMMON CANCER WORLDWIDE AND IN THE US1 More than 9500 people are diagnosed with skin cancer every day in the US2 Epidemiology of skin cancer About 5.4 million nonmelanoma skin cancer (NMSC) cases are diagnosed each year in the US. About two-thirds of these cases are basal cell carcinoma (BCC) and one-third are squamous cell carcinoma …
UV EXPOSURE Exposure to ultraviolet (UV) radiation from sunlight or indoor tanning increases the risk of all skin cancers SKIN CANCER BY GENDER • Women have a higher incidence of skin cancer before age 50. However, men over 50 have a higher risk • Indoor tanning is more common among young women ADDITIONAL RISK FACTORS • Light skin color is a major risk factor for all skin …
LUNGevity invited ACCC and other stakeholders across the oncology world to Washington DC, for their second Health Equity Summit on Tuesday, March 12.
ACCC NATIONAL ONCOLOGY CONFERENCE (NOC) 1 Sponsorship & Exhibit Rules & Regulations Eligibility for Sponsoring & Exhibiting The NOC is an ACCC premiere event. Its purpose is to enhance the professional development of its members. Accordingly, ACCC reserves the exclusive and total right to control all aspects of the conduct of the meeting, sponsorships, and exhibits. ACCC …